Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hepatitis C, Chronic D019698 12 associated lipids
Coronary Stenosis D023921 6 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Encephalitis D004660 15 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Contracture D003286 3 associated lipids
Stomatitis D013280 14 associated lipids
Weight Loss D015431 56 associated lipids
Endotoxemia D019446 27 associated lipids
Blister D001768 16 associated lipids
Memory Disorders D008569 33 associated lipids
Acute Lung Injury D055371 33 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Lupus Nephritis D008181 8 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Ileal Diseases D007077 3 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Gliosis D005911 6 associated lipids
Neuralgia D009437 28 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Amnesia D000647 12 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Sneezing D012912 6 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Liver Failure D017093 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Helicobacter Infections D016481 21 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Mucositis D052016 7 associated lipids
Ileitis D007079 2 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Venous Thrombosis D020246 11 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Partrick DA et al. Hypertonic saline activates lipid-primed human neutrophils for enhanced elastase release. 1998 J Trauma pmid:9555828
Cherniad'eva IF et al. [Characteristics of development of oxidative stress in blood plasma of patients with familial hypercholesterolemia]. 1998 Biull Eksp Biol Med pmid:9559141
Lallès JP et al. Small intestinal motility disorders in preruminant calves chronically fed a diet based on antigenic soya: characterization and possible mediators. 1998 Jan-Feb Vet. Res. pmid:9559521
Michibayashi T Neurogenic inhibitory action through platelets of platelet activating factor (PAF) on vasoconstrictive responsiveness to pressor agents. 1997 Adv. Exp. Med. Biol. pmid:9561145
Ishii I et al. High and low affinity mutants of platelet-activating factor receptor. 1997 Adv. Exp. Med. Biol. pmid:9561146
Heller A et al. Lipid mediators in inflammatory disorders. 1998 Drugs pmid:9561339
Wei Y et al. Structure of a microbial homologue of mammalian platelet-activating factor acetylhydrolases: Streptomyces exfoliatus lipase at 1.9 A resolution. 1998 Structure pmid:9562561
Akiyama M et al. Identification of a major PAF acetylhydrolase in human serum/plasma as a 43 kDa glycoprotein containing about 9 kDa asparagine-conjugated sugar chain(s). 1998 J. Biochem. pmid:9562606
da Silva MB et al. Effect of ketoprofen on PAF-induced bovine platelet aggregation. 1998 Vet. J. pmid:9564275
Brunet J et al. In vitro antioxidant properties of calcium dobesilate. 1998 Fundam Clin Pharmacol pmid:9565776
Ezeamuzie CI et al. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent. 1997 Int. J. Immunopharmacol. pmid:9568547
Ruiz-Ortega M et al. Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation. 1998 Nephrol. Dial. Transplant. pmid:9568845
Snapper JR et al. Effect of platelet-activating factor-receptor antagonism on endotoxin-induced lung dysfunction in sheep. 1998 J. Appl. Physiol. pmid:9572806
Cines DB et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. 1998 Blood pmid:9572988
Thijs A and Thijs LG Pathogenesis of renal failure in sepsis. 1998 Kidney Int. Suppl. pmid:9573570
Kitayama J et al. The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow. 1998 J. Clin. Invest. pmid:9576767
Shindo K and Fukumura M Oxatomide inhibits synthesis and release of platelet-activating factor in human neutrophils. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9578146
Ereth MH et al. The relation between the platelet-activated clotting test (HemoSTATUS) and blood loss after cardiopulmonary bypass. 1998 Anesthesiology pmid:9579505
Hüseyinov A et al. Plasma and urinary platelet activating factor concentrations and leukotriene releasing activity of leukocytes in steroid sensitive nephrotic syndrome of childhood. 1998 Acta Paediatr Jpn pmid:9583202
Takasaki J et al. Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism. 1998 J. Immunol. pmid:9590257
Pietsch P et al. Effects of platelet-activating factor on intracellular Ca2+ concentration and contractility in isolated cardiomyocytes. 1998 J. Cardiovasc. Pharmacol. pmid:9593076
Jackson JR et al. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. 1998 Biochim. Biophys. Acta pmid:9593866
Colak O et al. The effect of Ginkgo biloba on the activity of catalase and lipid peroxidation in experimental strangulation ileus. 1998 Int. J. Clin. Lab. Res. pmid:9594365
Wang F et al. [The effect of platelet activating factor on the biosynthesis of thromboxane A2 and prostaglandin I2 in human placental villi and umbilical artery]. 1997 Zhonghua Fu Chan Ke Za Zhi pmid:9596897
Yamada M et al. Inhibition of tumor necrosis factor-alpha production by SK&F 98625, a CoA-independent transacylase inhibitor, in cultured rat peritoneal macrophages. 1998 Life Sci. pmid:9600332
Lie WJ et al. Degranulation of human basophils by picomolar concentrations of IL-3, IL-5, or granulocyte-macrophage colony-stimulating factor. 1998 J. Allergy Clin. Immunol. pmid:9600507
Giménez R and Aguilar J Effects of CDP-choline administration on brain striatum platelet-activating factor in aging rats. 1998 Eur. J. Pharmacol. pmid:9600649
László F and Whittle BJ Role of nitric oxide and platelet-activating factor in the initiation of indomethacin-provoked intestinal inflammation in rats. 1998 Eur. J. Pharmacol. pmid:9600654
Gómez FP et al. The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma. 1998 Am. J. Respir. Crit. Care Med. pmid:9603138
O'Neill C Autocrine mediators are required to act on the embryo by the 2-cell stage to promote normal development and survival of mouse preimplantation embryos in vitro. 1998 Biol. Reprod. pmid:9603268
Kotelevets L et al. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3'-kinase is a critical mediator of tumor invasion. 1998 J. Biol. Chem. pmid:9603913
ZaÄ­tseva LG et al. [The role of platelet activating factor in regulation of the phagocytic function of macrophages from different organs]. 1998 Biull Eksp Biol Med pmid:9606554
Nguyen P et al. [Modulators of leukocytic functions]. 1998 J Mal Vasc pmid:9608925
Nakos G et al. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. 1998 Intensive Care Med pmid:9609406
Tsuji F and Shirasawa E The role of platelet-activating factor in cell infiltration in endotoxin-induced uveitis in guinea pigs. 1998 Curr. Eye Res. pmid:9617545
Shimada A et al. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. 1998 J. Invest. Dermatol. pmid:9620295
Mollinedo F et al. Physiological activation of human neutrophils down-regulates CD53 cell surface antigen. 1998 J. Leukoc. Biol. pmid:9620662
Lou YP et al. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways. 1998 Am. J. Respir. Crit. Care Med. pmid:9620929
Lapchyns'ka II [Platelet activating factor and its role in the pathogenesis of immune glomerulopathy]. 1998 Jan-Feb Lik. Sprava pmid:9621619
Isumi H et al. Expression of a 45K subunit of platelet-activating factor acetylhydrolase in the developing mouse cerebellum. 1998 Anat. Embryol. pmid:9623676
Gómez FP et al. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. 1998 Eur. Respir. J. pmid:9623685
Werr J et al. beta1 integrins are critically involved in neutrophil locomotion in extravascular tissue In vivo. 1998 J. Exp. Med. pmid:9625769
Takada Y et al. Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. 1998 Surgery pmid:9626320
Spapen H et al. The platelet-activating factor antagonist BB-882 does not improve tissue oxygen extraction in endotoxic shock. 1998 J Crit Care pmid:9627275
De Plaen IG et al. Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. 1998 Biochim. Biophys. Acta pmid:9630621
Baker RR and Chang H MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities. 1998 Biochim. Biophys. Acta pmid:9630721
Beck-Speier I et al. Pro-inflammatory response of alveolar macrophages induced by sulphite: studies with lucigenin-dependent chemiluminescence. 1998 Mar-Apr J. Biolumin. Chemilumin. pmid:9633012
Grassi S et al. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei. 1998 J. Neurophysiol. pmid:9636125
Izuoka T et al. Role of platelet-activating factor on extravascular lung water after coronary reperfusion in dogs. 1998 Jpn. J. Physiol. pmid:9639551
Mackness B et al. Lack of protection against oxidative modification of LDL by avian HDL. 1998 Biochem. Biophys. Res. Commun. pmid:9642147